Bambusa Stannum Liquid
FDA Label NDC 48951-2018

8 label sections · Submitted to the FDA by Uriel Pharmacy Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Uriel Pharmacy Inc. for the product Bambusa Stannum (NDC 48951-2018). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - purpose, indications & usage, dosage & administration, inactive ingredient, otc - active ingredient, warnings, otc - keep out of reach of children, otc - questions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Otc - Purpose

Use: Temporary relief of headache.

Otc - Active Ingredient

Active Ingredients: Bambusa (Bamboo) 6X, Betonica (Wood betony) 6X, Disci interv. (Bovine intervertebral discs of the cervical, thoracic and lumbar spine) 6X, Rosmarinus (Rosemary) 6X, Formica (Red wood ant) 7X, Stannum (Metallic tin) 7X, Jasper (Semiprecious stone) 12X, Equisetum (Common horsetail) 15X

Otc - Keep Out Of Reach Of Children

KEEP OUT OF REACH OF CHILDREN.

* Please review the disclaimer below.